Androgenetic alopecia and other hair-loss conditions result from follicle miniaturisation, stem-cell exhaustion within the dermal papilla, and inflammatory signalling that disrupts the hair growth cycle.
Stem cell therapy for Hair Loss & Restoration is an investigational regenerative approach that uses living cells — such as mesenchymal stem cells and exosomes — to target the disease process. Exosome and fibroblast scalp protocols aim to revitalise hair follicles and the scalp microenvironment for androgenetic and diffuse hair loss. It is not an approved cure for Hair Loss & Restoration: results come from early-phase clinical trials and clinic case series, not large randomised studies, and the realistic goal is slowed progression or symptom improvement rather than reversal.
Androgenetic alopecia and other hair-loss conditions result from follicle miniaturisation, stem-cell exhaustion within the dermal papilla, and inflammatory signalling that disrupts the hair growth cycle. Exosomes derived from umbilical-cord fibroblasts and mesenchymal stem cells contain growth factors (bFGF, VEGF, HGF), microRNAs (miR-29b regulating collagen cross-linking), and lipid mediators that promote angiogenesis, collagen deposition, and hair-follicle neogenesis in preclinical models. Sixteen registered clinical trials and four actively recruiting studies assess topical, intradermal, and systemic exosome formulations alongside platelet-rich plasma and conventional minoxidil or finasteride regimens.
| Indicative cost · Bulgaria (EU) | €3,000–€8,000 |
|---|---|
| Global market cost range | €1,840–€5,520 (dvcstem.com) |
| Main cell types studied | Exosomes, Fibroblasts from Wharton's Jelly |
| Approval status | Investigational |
| Registered trials (ClinicalTrials.gov) | 16 · 4 recruiting now |
For the clinic's own description, see our partner clinic Stem Plus.
Representative trials document hair density and thickness metrics using phototrichography and image analysis. Phase I–II cohorts report mean hair density increase of 15–35% over baseline in 50–65% of participants within 4–6 months of intradermal exosome injection or topical serum application. Terminal hair transition (vellus to terminal fibre diameter) occurs in 30–45%. Blinded assessor ratings and patient self-assessment show concordance in approximately 60–70% of cases. Durability studies extend to 12–18 months; some re-growth stabilises, whilst other patients require re-treatment.
Depending on assessment, a Hair Loss & Restoration protocol may draw on:
Hair-loss exosome treatments in Sofia clinics range €3,000–6,500 for complete courses, typically involving 4–6 intradermal injections spaced monthly, supplemented by topical exosome serum (applied 2–3 times weekly for 3–6 months). Cost drivers include exosome concentration, cell-culture scale-up, sterilisation, and clinical assessment (scalp imaging, follicle counting). Combination with platelet-rich plasma or growth-factor cocktails adds €500–1,500 per session.
Indicative EU treatment cost is €3,000–€8,000 versus roughly €15,000–35,000 in the US or Germany. Build your real all-in total with the cost calculator, see the Hair Loss & Restoration cost-by-country breakdown, or compare the best countries for Hair Loss & Restoration →
Before booking, check safety & regulation, the recovery climate, whether you may be a candidate, and which cell type fits Hair Loss & Restoration.
Full Hair Loss & Restoration FAQ → · Hair Loss & Restoration cost breakdown →
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
Useful tools & guides: Am I a candidate? · Which cell type? · Types of clinics & best countries · Cost calculator
Medically reviewed by StemCellAtlas’s editorial team with the Stem Plus medical team (physicians & scientists · GMP-certified Sofia laboratory · 25+ yrs international experience) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Last reviewed 2026-07-23; see our editorial standards. Educational information, not medical advice; figures indicative.
StemCellAtlas is your guide to stem-cell therapy: what the evidence shows, which conditions are treated, and the real all-in cost by country — typically €3,000–8,000 with our partner Stem Plus (Sofia), Europe's lowest-cost EU destination, versus $15,000–35,000 in the US.
Get an honest assessment